• 3rd Cancer Centre in Solapur ready to be operational by March
• Two new Hospitals announced in Indore and Raipur
• In dialogue with Boston Children’s Hospital, Memorial Sloan Kettering Cancer Center and National Cancer Institute, USA for Clinical Research in Paediatric Cardiac Sciences and Cancer
Mumbai, 25th January 2019 (GPN) : One of India’s top Multispecialty Healthcare Institutes, Kokilaben Dhirubhai Ambani Hospital (KDAH) and Medical Research Institute, today celebrated 10 years of its commitment to redefining healthcare services in India. Chairperson, Ms Tina Ambani and acclaimed actor Shri Amitabh Bachchan graced the occasion with their presence.
Commenting on the ten year journey of KDAH, Ms Tina Ambani, Chairperson said, “In the past 10 years, we have committed ourselves to transforming healthcare in India by making it more accessible and building awareness to make people more proactive, rather than reactive about their health; employing the best technology and treatment protocols in the world; and striving to create an ecosystem of inclusion by working together with other likeminded organisations. On this milestone, we reiterate our determination to extend our embrace of care and compassion, strive harder and aim higher to give Indians the healthcare they truly deserve.”
Furthering their commitment to healthcare in the country, opening of two new hospitals in Indore and Raipur by 2020 was announced. As part of the initiative to open 18 Cancer Care Centres across Maharashtra two Centres in Akola and Gondia have already been launched with a third in Solapur, ready to open by March. Clinics and Telemedicine Centres in Surat and Rajkot are active since 2016.
Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute is in dialogue with Boston Children’s Hospital, Memorial Sloan Kettering Cancer Center & National Cancer Institute, USA for Clinical Research in Paediatric Cardiac Sciences and Cancer. Taking the cause of Medical Research ahead in the country, the Institute has conducted over 112 Research Projects, 22 International Multi-centric Drug Trials and published 138 Research Papers in International Research Journals. The institute is among the leaders in the world in research on Wilson Disease, having identified genetic mutations specific to Indian patients with Wilson’s disease.
Dr. Ram Narain, Executive Director, said, “Medical Excellence and Research have been our focus through the last decade of distinction at Kokilaben Hospital. In the coming years, we will strive to raise the bar in terms of Clinical Excellence, launch new programmes to further bridge gaps and engage in path breaking research that benefits the country at large.”
In the field of Academics, the hospital offers a Masters in Emergency Medicine (MEM) program with George Washington University, USA. Kokilaben also started the first Varian Clinical School for Stereotactic Radiotherapy in Asia and the da Vinci Epicentre for Robotic UroOncology to train UroOncologists from the SAARC Region.
A healthcare landmark in India, the Hospital sees 265000 Outpatient cases and has 40000 plus inpatient Admissions every year with over 20% of patients coming from the rest of India. Over 7000 Children Heart Surgeries have been done with 60% of these being in babies less than 30 days old. With a success rate of 97% the outcomes are at par with Boston Children’s Heart Hospital, USA. Having done more than 600 Robotic Surgeries in 2018, we run the largest programme in the country. ENDS